OptimizeRx
OPRX
110 hedge funds and large institutions have $196M invested in OptimizeRx in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 39 closing their positions.
649% more call options, than puts
Call options by funds: $10.6M | Put options by funds: $1.42M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.81% less ownership
Funds ownership: 79.26% → 78.45% (-0.81%)
14% less funds holding
Funds holding: 128 → 110 (-18)
14% less capital invested
Capital invested by funds: $228M → $196M (-$32.1M)
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
44% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$10.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.97M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.79M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.75M |
| 5 |
Millennium Management
New York
|
+$4.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$28M |
| 2 |
State Street
Boston,
Massachusetts
|
-$4.65M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.62M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.07M |
| 5 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$3.87M |
OPRX Hedge Fund Activity: Q1 2023 in Review
110 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2023, worth a combined $196M — down 14% from $228M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of OPRX and 22 opened new positions — a net loss of 17 holders — while 40 trimmed existing stakes and 33 added.
The largest buyer was First Light Asset Management, adding an estimated $10.9M. The largest seller was BlackRock, cutting an estimated $28M.
- 110 institutional investors held OptimizeRx (OPRX) as of Q1 2023, down from 128 in Q4 2022.
- Funds reported $196M of OptimizeRx stock for Q1 2023, down 14% quarter-over-quarter.
- 22 funds opened new OptimizeRx positions in Q1 2023 and 39 closed out, a net change of -17 holders.
- The largest OptimizeRx buyer in Q1 2023 was First Light Asset Management, an estimated $10.9M added.
- The largest OptimizeRx seller in Q1 2023 was BlackRock, an estimated $28M sold.
Based on aggregated 13F filings for Q1 2023.